Atlas Trials

Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.

Clinical trial NCT07615101 · RECRUITING

Trial details

NCT number
NCT07615101
Sponsor
Norroy Bioscience Co., LTD
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer (Diagnosis)
Start date
2026-08-06
Primary completion
2027-06-30
Enrollment
365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.